This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Retinol Dehydrogenase 11 (RDH11) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine retinol dehydrogenase 11. It can be applied to WB, ICC/IF, IHC and FACS assays of canine retinol dehydrogenase 11.
Specifications
Target Information
Canine retinol dehydrogenase 11 (RDH11) is a microsomal short-chain dehydrogenase/reductase enzyme that recognizes all-trans and cis-retinoids as substrates and prefers NADPH as a cofactor. It plays a significant role in the visual cycle and the metabolism of vitamin A, particularly in the conversion of retinaldehyde to retinol. RDH11 is essential for maintaining retinol homeostasis in the liver and testis, especially under conditions of reduced vitamin A availability. Its function in extraocular tissues and embryos is also being studied, with recent findings indicating that RDH11 contributes to the maintenance of retinol levels under vitamin A deficiency or reduced vitamin A utilization. The enzyme's activity and regulation are crucial for understanding canine vitamin A metabolism and could have implications for managing related health conditions in dogs.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.